SightfileU.S. market data from official filings

DEFINIUM THERAPEUTICS F (DFTX)

Name: DEFINIUM THERAPEUTICS F (DFTX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001813814 · EDGAR filings · Updated 2026-06-26

DEFINIUM THERAPEUTICS F (DFTX) has 246 institutional managers reporting positions valued at $1.47B per the latest 13F reporting period.

Institutional managers

246

Reported 13F value

$1.47B

Insider activity

17 trans.

−$2.11M net selling

Latest updates

2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-25 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, DEFINIUM THERAPEUTICS F has 246 institutional holders.

Insider activity

Insiders reported 17 transactions (0 buys, 12 sells) across 5 reporting insiders, with a net reported value of −$2.11M.

Related companies

PACS GROUP (PACS) · ORIC PHARMACEUTICALS INC (ORIC) · TANDEM DIABETES CARE INC COM NEW (TNDM) · ATRICURE INC (ATRC) · DAMORA THERAPEUTICS INC (DMRA) · MONTE ROSA THERAPEUTICS INC (GLUE)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-26.